Curosurf, 240 mg/3 ml, suspensão para instilação endotraqueobrônquica
Phase 2 small_molecule active
Quick answer
Curosurf, 240 mg/3 ml, suspensão para instilação endotraqueobrônquica for Premature infants with Respiratory Distress Syndrome (RDS) is a Phase 2 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Institut für biomedizinische Analytik NMR-Imaging GmbH
- Indication
- Premature infants with Respiratory Distress Syndrome (RDS)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active